Literature DB >> 19077861

Structural and organizational determinants of quality of care in patients with schizophrenia in Italy.

Paola Bollini1, Sandro Pampallona, Giuseppe Tibaldi, Maurizio Bianco, Salvatore Nieddu, Carmine Munizza.   

Abstract

Several reports have described the poor quality of care delivered to psychotic patients. However, the context in which care was delivered, including the structure, organization, and performance of the health care system, as a possible determinant of quality of care has received less attention. In this study we explored the relationship between conformance with guidelines and structural and organizational characteristics in 2 departments of Mental Health in Italy. Dosing of antipsychotic drugs in the maintenance phase was investigated in 125 patients. Higher than recommended doses could be explained by the high patient caseload per psychiatrist, leading to insufficient contacts with patients and their families and to excessive reliance upon drug treatment. The analysis of structural and organizational determinants of care at the local level may help to explain insufficient quality and to plan suitable interventions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19077861     DOI: 10.1097/NMD.0b013e31818eea6e

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  2 in total

1.  Quality of care indicators for schizophrenia: determinants of observed variations among Italian Departments of Mental Health. Results from the ETAS DSM study.

Authors:  G Fantini; G Tibaldi; P Rucci; D Gibertoni; M Vezzoli; L Cifarelli; R Tiraferri; C Munizza
Journal:  Epidemiol Psychiatr Sci       Date:  2016-03-28       Impact factor: 6.892

2.  Risperidone-induced metabolic dysfunction is attenuated by Curcuma longa extract administration in mice.

Authors:  Florent Auger; Françoise Martin; Olivier Pétrault; Jennifer Samaillie; Thierry Hennebelle; Mohamed-Sami Trabelsi; François Bailleul; Bart Staels; Régis Bordet; Patrick Duriez
Journal:  Metab Brain Dis       Date:  2017-10-16       Impact factor: 3.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.